Potentiation by nitric oxide of the ATP-sensitive K+ current induced by K+ channel openers in guinea-pig ventricular cells

British Journal of Pharmacology

Volumn 120, Issue 8, 1997, Pages 1568-1574

  Shinbo, Atsushi ^a   Iijima, Toshihiko ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

8 Br cyclic GMP; ATP sensitive K+ channel; Cromakalim; K+ channel opener; KRN4884; Nitric oxide; NO donor; NOR3; Patch clamp; Ventricular myocytes

Indexed keywords

4 AMINO N [2 (2 CHLOROPHENYL)ETHYL] N' CYANO 3 PYRIDINECARBOXAMIDINE; 5 AMINO N [2 (2 CHLOROPHENYL)ETHYL] N' CYANO 3 PYRIDINECARBOXAMIDINE; 8 BROMO CYCLIC GMP; ADENOSINE TRIPHOSPHATE; CROMAKALIM; GLIBENCLAMIDE; NITRIC OXIDE; NITRIC OXIDE DONOR; OXYHEMOGLOBIN; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM ION; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; GUINEA PIG; HEART MUSCLE CELL; HEART VENTRICLE WALL; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL;

EID: 0030983706     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701069     Document Type: Article

References (26)

1. ARCHER, S. (1993). Measurement of nitric oxide in biological models. FASEB J., 7, 349-360.
2. BALLIGAND, J-L., KELLY, R.A., MARSDEN, P.A., SMITH, T.W. & MICHEL, T. (1993). Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. U.S.A., 90, 347-351.
3. BALLIGAND, J-L., KOBZIK, L., HAN, X., KAYE, D.M., BELHASSEN, L., O'HARA, D.S., KELLY, R.A., SMITH, T.W. & MICHEL, T. (1995). Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (Type III) nitric oxide synthase in cardiac myocytes. J. Biol. Chem., 270, 14582-14586.
4. BALLIGAND, J-L., UNGUREANU-LONGROIS, D., SIMMONS, W.W., PIMENTAL, D., MALINSKI, T.A., KAPTURCZAK, M., TAHA, Z., LOWENSTEIN, C.J., DAVIDOFF, A.J., KELLY, R.A., SMITH, T.W. & MICHEL, T. (1994). Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J. Biol. Chem., 269, 27580-27588.
5. BOLOTINA, V.M., NAJIBI, S., PALACINO, J.J., PAGANO, P.J. & COHEN, R.A. (1994). Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature, 368, 850-853.
6. BRADY, A.J.B., POOLE-WILSON, P.A., HARDING, S.E. & WARREN, J.B. (1992). Nitric oxide production within cardiac myocytes reduces their contractility in endothoxemia. Am. J. Physiol., 263, H1963-H1966.
7. EDWARDS, G. & WESTON, A.H. (1993). The pharmacology of ATP-sensitive potassium channels. Annu. Rev. Pharmacol. Toxicol., 33, 597-637.
8. FINKEL, M.S., ODDIS, C.V., JACOB, T.D., WATKINS, S.C., HATTLER, B.G. & SIMMONS, R.L. (1992). Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science, 257, 387-389.
9. + channels. J. Biol. Chem., 263, 7933-7936.
10. GROVER, G.J. (1994). Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia. J. Cardiovasc. Pharmacol., 24 (suppl. 4), S18-S27.
11. HAMILL, O.P., MARTY, A., NEHER, E., SAKMANN, B. & SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch., 391, 85-100.
12. HAN, X., SHIMONI, Y. & GILES, W.R. (1994). An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J. Physiol., 476, 309-314.
13. HAN, X., SHIMONI, Y. & GILES, W.R. (1995). A cellular mechanism for nitric oxide-mediated cholinergic control of mammalian heart rate. J. Gen. Physiol., 106, 45-65.
14. HOSHIDA, S., YAMASHITA, N., IGARASHI, J., NISHIDA, M., HORI, M., KAMADA, T., KUZUYA, T. & TADA, M. (1995). Nitric oxide synthase protects the heart against ischemia-reperfusion injury in rabbits. J. Pharmacol. Exp. Ther., 274, 413-418.
15. ISENBERG, G. & KLÖCKNER, U. (1982). Calcium tolerant ventricular myocytes prepared by preincubation in a 'KB medium'. Pflügerx Arch., 395, 6-18.
16. KAYE, D.M., WIVIOTT, S.D., BALLIGAND, J-L., SIMMONS, W.W., SMITH, T.W. & KELLY, R.A. (1996). Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of contractile function in adult rat ventricular myocytes. Circ. Res., 78, 217-224.
17. KITA, Y., HIRASAWA, Y., MAEDA, K., NISHIO, M. & YOSHIDA, K. (1994). Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur. J. Pharmacol., 257, 123-130.
18. KOH, S.D., CAMPBELL, J.D., CARL, A. & SANDERS, K.M. (1995). Nitric oxide activates multiple potassium channels in canine colonic smooth muscle. J. Physiol., 489, 735-743.
19. + channels in cultured vascular smooth muscle cells. Circ. Res., 74, 471-476.
20. MARSDEN, P.A., SCHAPPERT, K.T., CHEN, H.S., FLOWERS, M., SUNDELL, C.L., WILCOX, J.N., LAMAS, S. & MICHEL, T. (1992). Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS. Lett., 307, 287-293.
21. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142.
22. MURPHY, M.E. & BRAYDEN, J.E. (1995). Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J. Physiol., 486, 47-58.
23. NICHOLS, C.G., RIPOLL, C. & LEDERER, W.J. (1991). ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. Cir. Res., 68, 280-287.
24. NODE, K., KITAKAZE, M., KOSAKA, H., KOMAMURA, K., MINAMINO, T., TADA, M., INOUE, M., HORI, M. & KAMADA, T. (1995). Plasma nitric oxide end products are increased in the ischemic canine heart. Biochem. Biophys. Res. Commun., 211, 370-374.
25. 2+ -independent nitric oxide synthase in the myocardium. Br. J. Pharmacol., 105, 575-580.
26. + channels through suppression of phosphofructokinase activity and inhibits glucose-induced insulin release in pancreatic β cells. J. Gen. Physiol., 104, 1079-1099.